Bookbuilding IPO | ₹1,857 Cr | Listed at BSE, NSE | Tue, Jul 30, 2024 - Thu, Aug 1, 2024
| Category | QIB | NII | Retail | Employees | Total | ||||
|---|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | Below ₹10L | Above ₹10L | Total NII | ||||
| Allocation (No. of shares) | 81,37,276 | 1,22,05,912 | 2,03,43,188 | 13,56,212 | 27,12,425 | 40,68,637 | 27,12,424 | 2,43,902 | 2,73,68,151 |
| Allotment price (Rs.) | 679 | 679 | 679 | 679 | 679 | 679 | 679 | 615 | 678 |
| No.of applications | 165 | 50 | 215 | 1,34,746 | 84,689 | 2,19,435 | 20,22,498 | 1,537 | 22,43,685 |
| No.of shares applied | 73,18,34,400 | 1,22,05,912 | 74,40,40,312 | 4,31,88,090 | 12,82,96,124 | 17,14,84,214 | 5,70,16,982 | 2,43,826 | 97,27,85,334 |
| Amount collected (Rs.cr.) | 49,691.56 | 828.78 | 50,520.34 | 2,932.47 | 8,711.31 | 11,643.78 | 3,871.45 | 15.00 | 65,996.66 |
| No.of times subscribed | 89.94 | 1.00 | 36.57 | 31.84 | 47.30 | 42.15 | 21.02 | 1.00 | 35.54 |
| No.of shares allotted | 81,37,327 | 1,22,05,912 | 2,03,43,239 | 13,56,215 | 27,12,432 | 40,68,647 | 27,12,431 | 2,43,826 | 2,73,68,143 |
| Amount (Rs.cr.) | 552.52 | 828.78 | 1,381.31 | 92.09 | 184.17 | 276.26 | 184.17 | 15.00 | 1,856.74 |
| No.of allottees | 165 | 50 | 215 | 4,403 | 8,806 | 13,209 | 1,23,292 | 1,537 | 1,38,253 |
Akums Drugs IPO is a public issue of 2.74 Cr equity shares. The issue offers 0.27 Cr shares to retail investors, 2.03 Cr shares to qualified institutional buyers, and 0.41 Cr shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| QIB | 2,03,43,188 | 1,381.30 | 74.33% |
| Anchor | 1,22,05,912 | 828.78 | 44.60% |
| QIB (Ex Anchor) | 81,37,276 | 552.52 | 29.73% |
| NII | 40,68,637 | 276.26 | 14.87% |
| bNII (> ₹10L) | 27,12,425 | 184.17 | 9.91% |
| sNII (< ₹10L) | 13,56,212 | 92.09 | 4.96% |
| Retail | 27,12,424 | 184.17 | 9.91% |
| Employee | 2,43,902 | 16.56 | 0.89% |
| Total | 2,73,68,151 | 1,858.30 | 100% |
A total of 1,22,05,912 shares at a price of Rs 679 per share will be allotted to the anchor investors.
| Anchor investors bid opening date | Jul 29, 2024 |
| Anchor investor price | ₹679.00 |
| Anchor investors as % of QIBs | 60.00% |
| No. of shares locked-in for 30 days | 61,02,956 |
| No. of shares locked-in for 90 days | 61,02,956 |
📑 Anchor Investor Allotment Letter
📊 Historic report - IPOs Anchor Investors Investment & Performance
The Akums Drugs IPO is subscribed 63.44 times by Aug 01, 2024 18:19.
| Investor Category | Subscription (times) |
|---|---|
| Qualified Institutional | 90.09 |
| Non Institutional | 42.1 |
| Retail Individual | 20.8 |
| Employee Reservations | 4.14 |
| Total Subscription | 63.44 |
An investor can apply in Akums Drugs IPO online via bank (using ASBA) or the broker (using UPI). The Akums Drugs IPO shares are offered online only.
The Akums Drugs IPO is subscribed 63.44 times by Aug 01, 2024 18:19.
The Akums Drugs IPO allotment status is expected on or around Friday, August 2, 2024. Visit Akums Drugs IPO allotment status to check.
The Akums Drugs IPO listing date is August 6, 2024. The equity share of Akums Drugs IPO will list on BSE, NSE.
Visit Akums Drugs IPO subscription status page for real-time bidding information about Akums Drugs IPO.
| IPO opens On | Tuesday, July 30, 2024 |
| IPO Closes On | Thursday, August 1, 2024 |
| Finalisation of Basis of Allotment | Friday, August 2, 2024 |
| Initiation of Refunds | Monday, August 5, 2024 |
| Credit of Shares to Demat Account | Monday, August 5, 2024 |
| IPO Listing Date | Tuesday, August 6, 2024 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO Live News |
| IPO Allotment Status |
| IPO Basis of Allotment Document |
| IPO FAQs |